Inter Pharma Public Company Limited manufactures, imports, and distributes dietary supplement products for humans and animals in Thailand. It operates through two segments, Human Healthcare and Animal Healthcare. The company offers human beauty products, such as medical supplies, nutrition therapy, cosmetics, supplementary foods, probiotic and prebiotic products, health food products, general food products, medical equipment and medicines, etc.; a range of wellness and anti-aging products; aesthetic products, such as anti-wrinkle creams, hyaluronic fillers, and EGF cosmeceuticals; and diagnostic products. It also provides pet healthcare and livestock products comprising medical supplies, nutrition therapy, vaccines, supplementary foods, probiotic and prebiotic products, animal health food products, premium grade animal foods, general formula animal foods, etc. In addition, the company offers nutraceuticals, medicated shampoos, cosmeceuticals, pet food, and livestock animal products. The company was founded in 2006 and is headquartered in Bangkok, Thailand.
What is Inter Pharma Public Company Limited stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Inter Pharma Public Company Limited stocks are traded under the ticker IPTBF.
What is Inter Pharma Public Company Limited revenue for the last year?▼
Inter Pharma Public Company Limited revenue for the last year amounts to 94.42M USD.
What is Inter Pharma Public Company Limited net income for the last year?▼
IPTBF net income for the last year is 1.73M USD.
Does Inter Pharma Public Company Limited pay dividends?▼
Yes, IPTBF dividends are paid annual. The last dividend per share was 0 USD. As of today, Dividend Yield (FWD)% is 0%.
In which sector is Inter Pharma Public Company Limited located?▼
Inter Pharma Public Company Limited operates in the Manufacturing sector.
When did Inter Pharma Public Company Limited complete a stock split?▼
The last stock split for Inter Pharma Public Company Limited was on May 07, 2024 with a ratio of 13:8.